What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Arndt Hartmann mainly focuses on Pathology, Cancer research, Cancer, Internal medicine and Breast cancer.
His Pathology research is multidisciplinary, incorporating elements of Bladder cancer and Fluorescence in situ hybridization.
His Cancer research research incorporates elements of DNA methylation and Carcinogenesis, microRNA, Gene, Mutation.
His Cancer research is multidisciplinary, relying on both Molecular biology and Wnt signaling pathway.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Oncology.
In his research on the topic of Breast cancer, Cell cycle is strongly related with Bioinformatics.
His most cited work include:
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer (865 citations)
- Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. (794 citations)
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study (665 citations)
What are the main themes of his work throughout his whole career to date?
Arndt Hartmann mostly deals with Internal medicine, Pathology, Oncology, Cancer research and Bladder cancer.
His study ties his expertise on Gastroenterology together with the subject of Internal medicine.
His research on Pathology frequently connects to adjacent areas such as Fluorescence in situ hybridization.
His research is interdisciplinary, bridging the disciplines of Proportional hazards model and Oncology.
His work in Cancer research addresses subjects such as Epigenetics, which are connected to disciplines such as DNA methylation.
His Bladder cancer research incorporates themes from Stage, Carcinoma in situ, Disease and Urology.
He most often published in these fields:
- Internal medicine (35.36%)
- Pathology (33.17%)
- Oncology (26.67%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (35.36%)
- Oncology (26.67%)
- Cancer research (24.18%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Oncology, Cancer research, Bladder cancer and Pathology.
His Breast cancer, Cohort, Clinical trial, Cancer and Chemotherapy investigations are all subjects of Internal medicine research.
His research in Oncology intersects with topics in Stage, PD-L1 and Proportional hazards model.
His work deals with themes such as microRNA, Gene, Metastasis, Colorectal cancer and Tissue microarray, which intersect with Cancer research.
His Bladder cancer research includes elements of Carcinoma in situ, Disease and Immune system.
His study in Immunohistochemistry, Carcinoma, Malignancy and Biopsy falls within the category of Pathology.
Between 2017 and 2021, his most popular works were:
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study (665 citations)
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy (491 citations)
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary areas of investigation include Internal medicine, Bladder cancer, Oncology, Cancer research and Immunohistochemistry.
His study looks at the relationship between Internal medicine and fields such as Gastroenterology, as well as how they intersect with chemical problems.
His Oncology research includes themes of Cancer, Breast cancer, Immunotherapy, Clinical trial and Chemotherapy.
His work in Cancer research tackles topics such as DNA methylation which are related to areas like Chromatin.
His Immunohistochemistry study is related to the wider topic of Pathology.
Arndt Hartmann specializes in Pathology, namely Carcinoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
